 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Battling qPCR Royalty Decline, Life Tech Reports 2 Percent Uptick in Q4 Genetic Analysis Revenues
February 07, 2013
Battling qPCR Royalty Decline, Life Tech Reports 2 Percent Uptick in Q4 Genetic Analysis Revenues
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA OK of Life Tech, Quidel C. Diff Assay Sets Stage for Future Cleared Tests on QuantStudio Dx
March 21, 2013 / PCR Insider - Life Technologies Launches QuantStudio Dx in Europe with Quidel C. Diff Assay
November 29, 2012 / PCR Insider - Life Tech to Market Dx Version of QuantStudio Platform; Developing Assays with Quidel
July 26, 2012 / PCR Insider - DiaGenic Adopts Life Tech QuantStudio Dx for Alzheimer's Test Development
June 6, 2013 / PCR Insider - Quidel Says Respiratory Products Drive Q1 Growth; Provides Update on MDx Uptake
April 25, 2013 / PCR Insider